Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Niessner

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
European Heart Journal|September 22, 2019
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyMaria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 28, 2021
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapyHeinz Drexel, Stuart J Pocock, Basil S Lewis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
Giornale Italiano Di Cardiologia (2006)|January 16, 2023
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgerySigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
European Heart Journal|September 22, 2019
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 7, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysisPaul M Haller, Niema Kazem, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 6, 2021
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyMaria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 28, 2021
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapyHeinz Drexel, Stuart J Pocock, Basil S Lewis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
Giornale Italiano Di Cardiologia (2006)|January 16, 2023
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgerySigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, et al.
Pageof 21